|
GB9619757D0
(en)
*
|
1996-09-21 |
1996-11-06 |
Knoll Ag |
Chemical process
|
|
WO2000000195A1
(en)
*
|
1998-06-30 |
2000-01-06 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition for the treatment of diabetes
|
|
JP2000080047A
(ja)
*
|
1998-06-30 |
2000-03-21 |
Takeda Chem Ind Ltd |
医 薬
|
|
US6974838B2
(en)
|
1998-08-24 |
2005-12-13 |
Sepracor Inc. |
Methods of treating or preventing pain using sibutramine metabolites
|
|
US6339106B1
(en)
|
1999-08-11 |
2002-01-15 |
Sepracor, Inc. |
Methods and compositions for the treatment and prevention of sexual dysfunction
|
|
US6331571B1
(en)
|
1998-08-24 |
2001-12-18 |
Sepracor, Inc. |
Methods of treating and preventing attention deficit disorders
|
|
US6476078B2
(en)
*
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
|
HK1040910B
(en)
*
|
1998-11-12 |
2009-06-26 |
Smithkline Beecham Plc |
Pharmaceutical composition for modified release of an insulin sensitiser and metformin
|
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
|
AR023700A1
(es)
*
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Plc |
Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
|
|
US6696495B2
(en)
|
1998-12-02 |
2004-02-24 |
Snowden Pharmaceuticals, Llc |
Treatment of disorders secondary to organic impairments
|
|
US6323242B1
(en)
|
1998-12-02 |
2001-11-27 |
Peter Sterling Mueller |
Treatment of disorders secondary to organic impairments
|
|
US6552087B1
(en)
|
1999-03-19 |
2003-04-22 |
Abbott Gmbh & Co. Kg |
Therapeutic agent comprising (+)-sibutramine
|
|
US6723717B1
(en)
|
1999-06-01 |
2004-04-20 |
The University Of Texas Southwestern Medical Center |
Sulfur-containing thyroxane derivatives and their use as hair growth promotors
|
|
CA2374260A1
(en)
|
1999-06-01 |
2000-12-07 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using sulfonyl thyromimetic compounds
|
|
US6680344B1
(en)
|
1999-06-01 |
2004-01-20 |
The University Of Texas Southwestern Medical Center |
Method of treating hair loss using diphenylmethane derivatives
|
|
GB9914744D0
(en)
*
|
1999-06-24 |
1999-08-25 |
Knoll Ag |
Therapeutic agents
|
|
US6399826B1
(en)
|
1999-08-11 |
2002-06-04 |
Sepracor Inc. |
Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
|
|
US6610887B2
(en)
|
2001-04-13 |
2003-08-26 |
Sepracor Inc. |
Methods of preparing didesmethylsibutramine and other sibutramine derivatives
|
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
|
JP4278652B2
(ja)
*
|
2002-10-05 |
2009-06-17 |
ハンミ ファーム． シーオー．， エルティーディー． |
結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物
|
|
US20050131074A1
(en)
*
|
2003-08-04 |
2005-06-16 |
Beckman Kristen M. |
Methods for treating metabolic syndrome
|
|
PE20050335A1
(es)
*
|
2003-08-07 |
2005-06-01 |
Sb Pharmco Inc |
Forma de dosificacion oral que comprende 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona y procedimiento para la preparacion
|
|
GB0318824D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Glaxo Group Ltd |
Novel composition
|
|
MXPA06004639A
(es)
*
|
2003-10-31 |
2006-06-27 |
Takeda Pharmaceutical |
Preparacion solida que comprende sensibilizador de insulina, secretagogo de insulina y ester de acidos grasos de polioxietileno sorbitano.
|
|
KR100627687B1
(ko)
*
|
2005-04-20 |
2006-09-25 |
주식회사 씨티씨바이오 |
시부트라민 유리염기 함유 조성물 및 이의 제조방법
|
|
US20070203111A1
(en)
|
2006-01-06 |
2007-08-30 |
Sepracor Inc. |
Cycloalkylamines as monoamine reuptake inhibitors
|
|
WO2008034142A2
(en)
|
2006-09-15 |
2008-03-20 |
Reviva Pharmaceuticals, Inc. |
Synthesis, methods of using, and compositions of cycloalkylmethylamines
|
|
US8604244B2
(en)
|
2010-07-02 |
2013-12-10 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
|
|
KR100812538B1
(ko)
*
|
2006-10-23 |
2008-03-11 |
한올제약주식회사 |
약물 제어방출형 메트포르민-글리메피리드 복합제제
|
|
KR20080046601A
(ko)
*
|
2006-11-22 |
2008-05-27 |
에스케이케미칼주식회사 |
보관안정성이 우수한 시부트라민 함유 포접복합체
|
|
EP2952522B1
(en)
|
2007-01-31 |
2019-10-30 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
AU2008232709C1
(en)
|
2007-03-28 |
2015-01-15 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
US20110027458A1
(en)
|
2009-07-02 |
2011-02-03 |
Dexcom, Inc. |
Continuous analyte sensors and methods of making same
|
|
KR20170058446A
(ko)
|
2010-08-13 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
AR088392A1
(es)
|
2011-10-18 |
2014-05-28 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos
|
|
RU2642074C2
(ru)
|
2011-12-30 |
2018-01-24 |
Ревива Фармасьютикалс, Инк. |
Композиции, синтез и способы применения производных фенилциклоалкилметиламина
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
CA2862038C
(en)
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
BR112015009470A2
(pt)
|
2012-11-01 |
2019-12-17 |
Aileron Therapeutics Inc |
aminoácidos dissubstituídos e seus métodos de preparação e uso
|
|
WO2016049359A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
US10253067B2
(en)
|
2015-03-20 |
2019-04-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|